CVS faces lawsuit for claims about a store-brand eye product

By Colman M. Herman
In the supermarket, consumers often pick store-brand products as less expensive alternatives to name brands. When it comes to prescription drugs, insurers require generics when available. The rationale: You can get essentially the same product for less.
But sometimes there are significant differences with potentially adverse health consequences.
Consider what happened to G. Dana MacDonald. The 91-year-old Belmont resident has an eye disease called age-related macular degeneration. His ophthalmologist prescribed a product from Bausch + Lomb called PreserVision AREDS2, a nutritional supplement proven in government clinical trials to slow the progression of his disease, which often leads to blindness.
In 2014, MacDonald switched to CVS’s Advanced Eye Health because it was half the price and claimed on its label to be “comparable to ongoing study formula in AREDS2.” Just how comparable it was is a matter of dispute — and at least one lawsuit.
Age-related macular degeneration, or AMD, blurs the sharp central vision, which allows us to see objects that are straight ahead. It accounts for more than 50 percent of all blindness in the United States, according to the National Eye Institute.
At the beginning of the last decade, a clinical trial conducted by the institute, called the Age-Related Eye Disease Study (AREDS), determined that a high-dose combination of five nutrients (vitamins C and E, beta-carotene, zinc, and copper) could reduce the risk of severe vision loss by 25 percent for many people with the disease…….
Read more:
Source: Boston Globe